Article | June 5, 2023

Chapel Hill's Jurata Thin Film Aims To Revolutionize Drug Delivery

Juratas thin-film technology.
Jurata's thin-film technology.

Imagine receiving a COVID-19 vaccine not from the jab of a needle and syringe but by slipping a thin, clear film smaller than a postage stamp inside your cheek or under your tongue and letting it dissolve. That’s one of the potential benefits of a new drug-delivery technology being developed by Jurata Thin Film, a startup company in Chapel Hill that was co-founded by two of North Carolina’s most successful bioscience entrepreneurs.

Jurata’s thin-film technology preserves the therapeutic activity of biological pharmaceutics by immobilizing them into a solid film matrix, like the way amber can preserve ancient plant and insect specimens trapped within. The technology allows vaccines and other lifesaving medications to be stored at room temperature for up to three years.

Learn more about Jurata’s revolutionary thin-film technology.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader

North Carolina Biotechnology Center